Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

PRESS RELEASE 11/9/2008

On 8th September 2008, the Danish Western High Court upheld a ruling from the Bailiff’s Court of Kolding, Denmark of 26th November 2007 in favour of Pharma Medico International ApS, owners of the NOURKRIN® Trademark, stating that the trademark NOURISEA infringed NOURKRIN® and that a former licensed manufacturer has misused trade secrets.

The facts of the case were:

On 12th October 2007, Irish Response Ltd., trading as Lifes2Good Ltd., applied for the trademark NOURISEA in the EU. A former licensed manufacturer of NOURKRIN® offered to manufacture the “NOURKRIN” product range for Irish Response Ltd., trading as Lifes2Good Ltd., under the name NOURISEA, using trade secrets it had previously obtained through manufacture of NOURKRIN®. Subsequently, Irish Response Ltd., trading as Lifes2Good Ltd., ordered the manufacture of significant quantities of NOURISEA products.

On 12th November 2007, the Bailiff’s Court of Kolding, Denmark, issued an injunction towards the former licensed manufacturer and seized significant quantities of boxes and finished goods bearing the name NOURISEA at the premises of the former licensed manufacturer cf. below.

Morten Christensen, CEO of Pharma Medico International ApS said, “As the legitimate owner of NOURKRIN® in the EU, we were confident that we would prevail in this case. We believe that the High Court’s ruling sends a strong message to those who continue to make false representations to consumers and the industry regarding the NOURKRIN® brand.” The Court’s granting of a summary judgment motion is part of Pharma Medico’s International ApS’s ongoing efforts to aggressively investigate and follow up infringement of its intellectual properties, and eliminate counterfeit versions of its products from the marketplace.

Following the ruling Pharma Medico International ApS is now in the process of quantifying the total financial claim for damages. Pharma Medico International ApS will actively continue to pursue any such cases through the proper legal channels. Pharma Medico International ApS was successfully represented by Lett Law Firm, Denmark; one of the five leading law firms in Denmark.

NOURKRIN® with MARILEX® is an award-winning food supplement which stimulates hair growth.

Morten Christensen / CEO
Pharma Medico International Graven 25B DK-8000 Århus C
Tlf.: +45 8619 0234 www.pharmamedico.com
www.nourkrin.com

Issued on behalf of Pharma Medico
By Partners in PR
Further info from jackie@partnersinpr.co.uk 01409 281749

This press release was distributed by ResponseSource Press Release Wire on behalf of Partners in PR Ltd in the following categories: Men's Interest, Health, Women's Interest & Beauty, Business & Finance, Medical & Pharmaceutical, for more information visit https://pressreleasewire.responsesource.com/about.